MedTrace Logo

Neurofeedback as a Treatment Tool for Depression

NCT01544205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of the study is to investigate whether neurofeedback delivered via functional magnetic resonance imaging signals can be used to train depressed patients to self-regulate emotion networks and whether this improves clinical symptoms.

Conditions

  • Unipolar Depression

Interventions

OTHER

fMRI-based neurofeedback

5 sessions lasting one hour each

Sponsors & Collaborators

  • Medical Research Council

    collaborator OTHER_GOV

  • National Institute for Social Care and Health Research

    collaborator UNKNOWN

  • Cardiff University

    lead OTHER

Principal Investigators

  • David E Linden, MD · Cardiff University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01544205 on ClinicalTrials.gov